Investigator Initiated Trial Confirms Safety of Silk-Elastin for Meniscus Injury－Multi-Center Collaborative Corporate Clinical Trial to Seek Approval for Meniscal Repair and Regeneration Medical Devices－
- 2024/05/21 News
Sanyo Chemical Industries, Ltd. and Hiroshima University are pleased to announce that an investigator-initiated clinical trial was conducted targeting patients with meniscus injuries (meniscus suture) using new treatment method using Silk-Elastin at Hiroshima University Hospital, and its safety was confirmed. Silk-Elastin is a functional protein with high potential as a scaffold for promoting repair and regeneration of living tissue.
Based on these results, Sanyo Chemical, together with Hiroshima University and others, will conduct a corporate clinical trial to confirm its efficacy and promote research and development toward commercialization.
＞Release：Investigator Initiated Trial Confirms Safety of Silk-Elastin for Meniscus Injury